Dopamine Receptor D1 (DRD1) (N-Term) Peptide
Quick Overview for Dopamine Receptor D1 (DRD1) (N-Term) Peptide (ABIN8099158)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- DRD1 Peptide - N-terminal region
-
Sequence
- AAFILISVAW TLSVLISFIP VQLSWHKAKP TSPSDGNATS LAETIDNCDS
-
-
Dopamine Receptor D1 (DRD1) peptide
DRD1 Host: Synthetic BP, WB, IHC
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-DRD1 Antibody (ARP63609_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Background
-
Background Information: This gene encodes the D1 subtype of the dopamine receptor. The D1 subtype is the most abundant dopamine receptor in the central nervous system. This G-protein coupled receptor stimulates adenylyl cyclase and activates cyclic AMP-dependent protein kinases. D1 receptors regulate neuronal growth and development, mediate some behavioral responses, and modulate dopamine receptor D2-mediated events.
Alternative Symbols: DADR, DRD1A
-
Molecular Weight
- 49kDa
-
Gene ID
- 1812
-
NCBI Accession
- NP_000785
-
UniProt
- P21728
Target
-
